Details for Patent: 9,597,281
✉ Email this page to a colleague
Which drugs does patent 9,597,281 protect, and when does it expire?
Patent 9,597,281 protects EDLUAR and is included in one NDA.
This patent has twenty patent family members in twelve countries.
Summary for Patent: 9,597,281
Title: | Pharmaceutical formulations useful in the treatment of insomnia |
Abstract: | There is provided a formulation suitable for transmucosal administration comprising a short acting hypnotic drug, which formulation provides a measurable plasma concentration of drug within 10 minutes of administration. The formulation is capable of providing sleep on demand, and preferably comprises particles of drug, for example zolpidem or a pharmaceutically-acceptable salt thereof and a mucoadhesion promoting agent, such as sodium carboxymethylcellulose, which particles of drug and mucoadhesive are presented upon the surface of larger carrier particles. |
Inventor(s): | Pettersson; Anders (Kode, SE), Nystrom; Christer (Lidingo, SE), Bredenberg; Susanne (Uppsala, SE) |
Assignee: | Orexo AB (Uppsala, SE) |
Application Number: | 13/870,737 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,597,281
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | EDLUAR | zolpidem tartrate | TABLET;SUBLINGUAL | 021997-001 | Mar 13, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET | ⤷ Try a Trial | |||
Mylan Speciality Lp | EDLUAR | zolpidem tartrate | TABLET;SUBLINGUAL | 021997-002 | Mar 13, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,597,281
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0423800.2 | Oct 27, 2004 |
International Family Members for US Patent 9,597,281
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Cyprus | 1118414 | ⤷ Try a Trial | |||
Cyprus | 1119580 | ⤷ Try a Trial | |||
Denmark | 1807156 | ⤷ Try a Trial | |||
Denmark | 2340872 | ⤷ Try a Trial | |||
European Patent Office | 1807156 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |